Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old
- You have been diagnosed with Irritable Bowel Syndrome (IBS) based on a standard set of medical guidelines called the Rome IV criteria
- Your IBS symptoms are rated as mild to moderate based on a standard symptom scoring tool
Who may not be able to join:
- You have other gut or digestive conditions whose symptoms could be confused with IBS, or you have other serious health conditions
- You have a severe mental health disorder with significant personality disturbances, or you have had thoughts of suicide or any self-harm in the past 12 months
- You are currently pregnant, planning to become pregnant, or breastfeeding
- You have difficulties with memory, thinking, or understanding (confirm with trial site)
- You have taken the medication pregabalin in the last 30 days, or you are known to be allergic to it
- You are currently taking certain medications that could interact with the study drug, including rosiglitazone, pioglitazone, opioid painkillers, anti-anxiety medicines, some non-opioid pain relievers, mexiletine, dextromethorphan, or sleeping tablets (confirm with trial site for a full list)
- You are currently taking a specific IBS medication called alosetron
- You drink more than 50 units of alcohol per week (where one unit equals 10 mL of pure alcohol)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fang Luo, Beijing Tiantan Hospital
Phone: +86 13611326978
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The IBS Severity Scoring System (IBS-SSS) and respnse rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.